Skip to main content

Table 1 Clinical characteristics of TCGA and GEO dataset

From: Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma

Variable

TCGA-LUAD dataset (N = 477) N(%)

GEO LUAD dataset (N = 318)

GSE30219 N(%)

GSE37745 N(%)

GSE50081 N(%)

Age

  < 68

261 (54.7)

61 (73.5)

71 (67.0)

48 (37.2)

  ≥68

216 (45.3)

22 (26.5)

35 (33.0)

81 (62.8)

Gender

    

 Female

257 (53.9)

18 (21.7)

60 (56.6)

62 (48.1)

 Male

220 (46.1)

65 (78.3)

46 (43.4)

67 (51.9)

Stage

 I

4 (0.8)

NA

NA

NA

 IA

124 (26.0)

NA

NA

37 (28.7)

 IB

125 (26.2)

NA

NA

56 (43.4)

 II

191 (40.0)

NA

NA

NA

 IIA

   

7 (5.4)

 IIB

   

29 (22.5)

 III

NA

NA

NA

0 (0)

 IV

25 (5.2)

NA

NA

0 (0)

 Unknow

8 (1.7)

NA

NA

0 (0)

T

 T1

159 (33.3)

69 (83.1)

NA

44 (34.1)

 T2

254 (53.2)

12 (14.5)

NA

83 (64.3)

 T3

43 (9.0)

2 (2.4)

NA

2 (1.6)

 T4

18 (3.8)

0 (0)

NA

0 (0)

 TX

3 (0.6)

0 (0)

NA

0 (0)

N

 N0

307 (64.4)

80 (96.4)

NA

95 (73.6)

 N1

90 (18.9)

3 (3.6)

NA

34 (26.4)

 N2

67 (14.0)

0 (0)

NA

0 (0)

 NX

2 (0.4)

0 (0)

NA

0 (0)

 Unknow

1 (0.2)

0 (0)

NA

0 (0)

M

 M0

313 (65.6)

83 (100)

NA

129 (100)

 M1

24 (5.0)

0 (0)

NA

0 (0)

 MX

136 (28.5)

0 (0)

NA

0 (0)